Donor Pretreatment with IL-1 Receptor Antagonist Attenuates Inflammation and Improves Functional Potency in Islets from Brain-Dead Nonhuman Primates

Management of the Brain-Dead Organ Donor

(2013) Tatiana H. Rech et al.   TRANSPLANTATION

Effects of brain death on organ quality and transplant outcome

(2012) Bernhard Floerchinger et al.   Transplantation Reviews

Anakinra Potentiates the Protective Effects of Etanercept in Transplantation of Marginal Mass Human Islets in Immunodeficient Mice

(2011) M. McCall et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Improving Efficacy of Clinical Islet Transplantation with Iodixanol-Based Islet Purification, Thymoglobulin Induction, and Blockage of IL-1β and TNF-α

(2011) Shinichi Matsumoto et al.   CELL TRANSPLANTATION

Early Activation of the Inflammatory Response in the Liver of Brain-Dead Non-Human Primates

(2011) Juan Sebastian Danobeitia et al.   JOURNAL OF SURGICAL RESEARCH

Systemic inflammation in the brain-dead organ donor

(2009) A. BARKLIN   ACTA ANAESTHESIOLOGICA SCANDINAVICA

Immunological and Inflammatory Functions of the Interleukin-1 Family

(2009) Charles A. Dinarello   Annual Review of Immunology

IL-1β receptor blockade protects islets against pro-inflammatory cytokine induced necrosis and apoptosis

(2009) Alice Schwarznau et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Methylprednisolone Therapy in Deceased Donors Reduces Inflammation in the Donor Liver and Improves Outcome After Liver Transplantation

(2008) Katja Kotsch et al.   ANNALS OF SURGERY

Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation*

(2008) Raghavan Murugan et al.   CRITICAL CARE MEDICINE